Ono type DX Breast Recurrence Score Test
Leeds Teaching Hospitals NHS Trust · Awarded
- Buyer
- Leeds Teaching Hospitals NHS Trust
- Status
- Awarded
- Country
- United Kingdom
- Region
- EU - Western Europe
- Sector
- Manufacturing
- Reference
- UK-CFA-ocds-b5fd17-3205757c-a10d-4c89-8861-ac69b727b6c4
- Published
- 2026-10-26
- Deadline
- 2026-06-30
Tender summary
Oncotype DX is a clinically validated multigene assay for predicting the likely benefit of chemotherapy in this patient population and is uniquely available from the current supplier on the global market.
This is a public summary of a procurement notice. Dates and status reflect the notice held by BidScout; check the full notice before bidding.
Full tender details have a three-minute guest preview for open opportunities. AI insights require registration.
Register for full access